期刊文献+

子宫内膜癌中磷酸化哺乳动物雷帕霉素靶蛋白的表达及临床意义

Expression and significance of phosphorylation-mammalian target of rapamycin in endometrial carcinoma
原文传递
导出
摘要 目的 探讨磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR)在良恶性子宫内膜病变组织中的表达情况.方法 应用免疫组化SP法检测45例子宫内膜样腺癌、7例子宫内膜非典型增生、6例增殖期子宫内膜组织中p-mTOR的表达情况.结果 p-mTOR主要分布于细胞质,在增殖期子宫内膜中呈弱阳性表达或阴性表达,蛋白颗粒密度为2.36±0.76 在子宫内膜非典型增生和子宫内膜样腺癌中高表达,蛋白颗粒密度分别为6.21±1.19、15.82±2.64,三者间比较差异有统计学意义(F=11.37,P<0.05).在子宫内膜样腺癌组织中,不同组织学分级p-mTOR表达差异有统计学意义(F=8.27,P<0.05),但不同病理分期p-mTOR表达差异无统计学意义(P>0.05).结论 p-mTOR可能参与了子宫内膜癌的发生和发展过程. Objective To investigate the expression of phosphorylation-mammalian target of rapamycin (p-mTOR) in endometrial carcinoma. Methods The expressions of p-mTOR protein in tissues from 45 cases of endometrial adenocarcinoma, 7 endometrial atypical hyperplasia, and 6 normal endometrium were detected by immunohistochemistry SP method. Results The expression of p-mTOR protein maily restricted to cytoplasm. Compared with normal endometrium, the expression of p-mTOR protein in the cases of endometrial atypical hyperplasia and endometrial adenocarcinoma was significantly up-regulation(2.36 ± 0.76vs 6.21 ± 1.19, 15.82 ± 2.64)( F = 11.37, P 〈 0.05 ). There was significant difference of p-mTOR protein in different histology class in endometrial adenocarcinoma (F = 8.27, P 〈 0.05), but there was no significant difference of p-mTOR protein in different pathological grade in endometrial adenocarcinoma (P 〉0.05).Conclusion The expression of p-mTOR protein may participate in the occurrence and development of endometrial carcinoma.
出处 《中国医师进修杂志》 2010年第18期21-23,共3页 Chinese Journal of Postgraduates of Medicine
关键词 子宫内膜肿瘤 他克莫司结合蛋白质类 细胞凋亡 免疫组织化学 Endometrial neoplasms Tacrolimus binding proteins Apoptosis Immunohistochemistry
  • 相关文献

参考文献7

  • 1Gera JF,Mellinghoff IK,Shi Y,et al. AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression.J Biol Chem,2004,279(4): 2737-2746.
  • 2Bjornsti MA,Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer,2004,4(5): 335-348.
  • 3Navé BT,Ouwens M,Withers DJ,et al. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J,1999,344 Pt 2:427-431.
  • 4Sahin F,Kannangai R,Adegbola O,et al. mTOR and P70 S6 kinase expression in primary liver neoplasms. Clin Cancer Res,2004,10(24):8421-8425.
  • 5Zhou X,Tan M,Stone Hawthorne V,et al. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers. Clin Cancer Res,2004,10(20): 6779-6788.
  • 6Faried LS,Faried A,Kanuma T,et al. Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy. Oncol Rep,2006,16(1):57-63.
  • 7Kremer CL,Klein RR,Mendelson J,et al. Expression of mTOR signaling pathway markers in prostate cancer progression. Prostate,2006,66(11): 1203-1212.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部